Home LifestyleWellness Approval for first drug designed to treat PPD

Approval for first drug designed to treat PPD

mother and baby

The United States Food and Drug Administration has recently approved the first-ever drug to fight postpartum depression (PPD). The new drug, brexanolone, is taken intravenously and over the course of 60 hours. Women tend to see relief within 48 hours of treatment.

This fast-acting drug isn’t cheap, but to many women its price tag is worth it. Each dosage vile is around $7,000, with the total treatment running around $30,000 before insurance, plus time spent in the hospital.

Sage Therapeutics, the company behind the drug, is working on a pill version that will be less expensive.

Katie Connor, 360 Media, Inc.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

The Atlanta 100